search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Dialysis circuit angiogram delineating the jump graft placed between the left cephalic and internal jugular veins. A short segment of graft-cephalic venous anastomosis stenosis is present.


Left: Pre-intervention angiogram revealing brachiocephalic occlusion and prominent surrounding venous collaterals. Right: Post-angioplasty demonstrating brachiocephalic recanalization, improved flow and resolution of surrounding venous collaterals.


arteriovenous fistula (AVF) the high flow rates increase the risk of venous hypertension.5–6


Often patients with


CVS do not require treatment unless they are symptomatic with significant arm swelling, SVC syndrome, or have poor functioning AVF and dialysis access as a result.


Main therapeutic options in these patients include venoplasty ± stenting, lead extraction with venoplasty ±


stenting, contralateral implantation of new CIED or placement of a “leadless pacemaker.”2


In a multicenter study,


27 patients with pacemaker lead- associated CVS, ipsilateral hemodialysis (HD) access and symptomatic swelling were treated with conventional balloon angioplasty with a 100% clinical success rate. Primary patency at 6 and 12 months was 18% and 9% respectively. Secondary patency defined as patency until access was revised


or abandoned was 95%, 86% and 73% at 6, 12 and 24 months, respectively. A mean of 2.1 procedures⁄year were required to maintain secondary patency and no procedural complications were encountered.8


A study of 14


dialysis patients with ipsilateral HD arteriovenous (AV) access who had symptomatic central venous stenosis or occlusion were treated with angioplasty and stenting to evaluate patency rates and complications with


irq.sirweb.org | 19


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40